List of Tables
Table 1. Global Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Therapeutic Drug Monitoring Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Therapeutic Drug Monitoring Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Therapeutic Drug Monitoring Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Therapeutic Drug Monitoring Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Therapeutic Drug Monitoring Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Therapeutic Drug Monitoring Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Therapeutic Drug Monitoring Revenue by Company (2020-2025) & (US$ Million)
Table 11. Therapeutic Drug Monitoring Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Therapeutic Drug Monitoring Players by Revenue (US$ Million) in 2024
Table 13. Global Therapeutic Drug Monitoring Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Therapeutic Drug Monitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Drug Monitoring as of 2024)
Table 15. Global Therapeutic Drug Monitoring Companies Headquarters
Table 16. Date of International Companies Enter into Therapeutic Drug Monitoring Market
Table 17. Global Therapeutic Drug Monitoring Companies Product & Service
Table 18. Global Therapeutic Drug Monitoring Mergers & Acquisitions, Expansion Plans
Table 19. Roche Corporation Information
Table 20. Roche Description and Business Overview
Table 21. Roche Therapeutic Drug Monitoring Product
Table 22. Roche Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Roche Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 24. Roche Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 25. Roche Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 26. Roche Recent Developments
Table 27. Danaher Corporation Information
Table 28. Danaher Description and Business Overview
Table 29. Danaher Therapeutic Drug Monitoring Product
Table 30. Danaher Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Danaher Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 32. Danaher Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 33. Danaher Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 34. Danaher Recent Developments
Table 35. Abbott Corporation Information
Table 36. Abbott Description and Business Overview
Table 37. Abbott Therapeutic Drug Monitoring Product
Table 38. Abbott Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Abbott Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 40. Abbott Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 41. Abbott Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 42. Abbott Recent Developments
Table 43. Thermo Fisher Scientific Corporation Information
Table 44. Thermo Fisher Scientific Description and Business Overview
Table 45. Thermo Fisher Scientific Therapeutic Drug Monitoring Product
Table 46. Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 48. Thermo Fisher Scientific Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 49. Thermo Fisher Scientific Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 50. Thermo Fisher Scientific Recent Developments
Table 51. Siemens Healthineers Corporation Information
Table 52. Siemens Healthineers Description and Business Overview
Table 53. Siemens Healthineers Therapeutic Drug Monitoring Product
Table 54. Siemens Healthineers Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Siemens Healthineers Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 56. Siemens Healthineers Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 57. Siemens Healthineers Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 58. Siemens Healthineers Recent Developments
Table 59. Bio-Rad Laboratories Corporation Information
Table 60. Bio-Rad Laboratories Description and Business Overview
Table 61. Bio-Rad Laboratories Therapeutic Drug Monitoring Product
Table 62. Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Bio-Rad Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 64. Bio-Rad Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 65. Bio-Rad Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 66. Bio-Rad Laboratories Recent Developments
Table 67. bioMerieux Corporation Information
Table 68. bioMerieux Description and Business Overview
Table 69. bioMerieux Therapeutic Drug Monitoring Product
Table 70. bioMerieux Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. bioMerieux Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 72. bioMerieux Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 73. bioMerieux Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 74. bioMerieux Recent Developments
Table 75. Bühlmann Laboratories Corporation Information
Table 76. Bühlmann Laboratories Description and Business Overview
Table 77. Bühlmann Laboratories Therapeutic Drug Monitoring Product
Table 78. Bühlmann Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Bühlmann Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 80. Bühlmann Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 81. Bühlmann Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 82. Bühlmann Laboratories Recent Developments
Table 83. Randox Laboratories Corporation Information
Table 84. Randox Laboratories Description and Business Overview
Table 85. Randox Laboratories Therapeutic Drug Monitoring Product
Table 86. Randox Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Randox Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 88. Randox Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 89. Randox Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 90. Randox Laboratories Recent Developments
Table 91. Sekisui Medical Corporation Information
Table 92. Sekisui Medical Description and Business Overview
Table 93. Sekisui Medical Therapeutic Drug Monitoring Product
Table 94. Sekisui Medical Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Sekisui Medical Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 96. Sekisui Medical Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 97. Sekisui Medical Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 98. Sekisui Medical Recent Developments
Table 99. DAT Diagnostic Corporation Information
Table 100. DAT Diagnostic Description and Business Overview
Table 101. DAT Diagnostic Therapeutic Drug Monitoring Product
Table 102. DAT Diagnostic Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. DAT Diagnostic Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 104. DAT Diagnostic Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 105. DAT Diagnostic Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 106. DAT Diagnostic Recent Developments
Table 107. Chromai Corporation Information
Table 108. Chromai Description and Business Overview
Table 109. Chromai Therapeutic Drug Monitoring Product
Table 110. Chromai Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Chromai Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
Table 112. Chromai Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
Table 113. Chromai Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
Table 114. Chromai Recent Developments
Table 115. North America Therapeutic Drug Monitoring Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Therapeutic Drug Monitoring Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Therapeutic Drug Monitoring Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Therapeutic Drug Monitoring Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Therapeutic Drug Monitoring Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Therapeutic Drug Monitoring Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Therapeutic Drug Monitoring Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Therapeutic Drug Monitoring Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Therapeutic Drug Monitoring Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Therapeutic Drug Monitoring Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
Table 135. Therapeutic Drug Monitoring Key Raw Materials, Industry Status and Trend
Table 136. Therapeutic Drug Monitoring Key Raw Materials and Upstream Suppliers
Table 137. Therapeutic Drug Monitoring Clients Status and Trend
Table 138. Therapeutic Drug Monitoring Typical Clients
Table 139. Therapeutic Drug Monitoring Distributors
Table 140. Therapeutic Drug Monitoring Market Trends
Table 141. Therapeutic Drug Monitoring Market Drivers
Table 142. Therapeutic Drug Monitoring Market Challenges
Table 143. Therapeutic Drug Monitoring Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Drug Monitoring Product Picture
Figure 2. Global Therapeutic Drug Monitoring Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Therapeutic Drug Monitoring Revenue Market Share by Type in 2024 & 2031
Figure 4. Blood Test Product Picture
Figure 5. Urine Test Product Picture
Figure 6. Saliva Test Product Picture
Figure 7. Global Therapeutic Drug Monitoring Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Therapeutic Drug Monitoring Revenue Market Share by Application in 2024 & 2031
Figure 9. Hospital Labs
Figure 10. Independent Clinical Laboratories
Figure 11. Others
Figure 12. Therapeutic Drug Monitoring Report Years Considered
Figure 13. Global Therapeutic Drug Monitoring Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Therapeutic Drug Monitoring Market Size (2020-2031) & (US$ Million)
Figure 15. Global Therapeutic Drug Monitoring Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Therapeutic Drug Monitoring Revenue Market Share by Region (2020-2031)
Figure 17. Global Therapeutic Drug Monitoring Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Therapeutic Drug Monitoring Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Blood Test of Therapeutic Drug Monitoring Revenue Market Share by Application, 2024 VS 2031
Figure 20. Urine Test of Therapeutic Drug Monitoring Revenue Market Share by Application, 2024 VS 2031
Figure 21. Saliva Test of Therapeutic Drug Monitoring Revenue Market Share by Application, 2024 VS 2031
Figure 22. Therapeutic Drug Monitoring Revenue Share by Company (2024)
Figure 23. Therapeutic Drug Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Blood Test Revenue Proportion by Company in 2024
Figure 25. Urine Test Revenue Proportion by Company in 2024
Figure 26. Saliva Test Revenue Proportion by Company in 2024
Figure 27. North America Therapeutic Drug Monitoring Revenue 2020-2031 (US$ Million)
Figure 28. North America Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
Figure 29. North America Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
Figure 30. Asia-Pacific Therapeutic Drug Monitoring Revenue 2020-2031 (US$ Million)
Figure 31. Asia-Pacific Therapeutic Drug Monitoring Revenue Market Share by Region (2020-2031)
Figure 32. Asia-Pacific Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
Figure 33. Asia-Pacific Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
Figure 34. Europe Therapeutic Drug Monitoring Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Europe Therapeutic Drug Monitoring Revenue Market Share by Country (2020-2031)
Figure 36. Europe Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
Figure 37. Europe Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
Figure 38. Latin America Therapeutic Drug Monitoring Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Latin America Therapeutic Drug Monitoring Revenue Market Share by Country (2020-2031)
Figure 40. Latin America Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
Figure 41. Latin America Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
Figure 42. Middle East and Africa Therapeutic Drug Monitoring Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Country (2020-2031)
Figure 44. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
Figure 45. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
Figure 46. Therapeutic Drug Monitoring Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Therapeutic Drug Monitoring Raw Materials by Region in 2024
Figure 48. Therapeutic Drug Monitoring Distribution Channels
Figure 49. Global Therapeutic Drug Monitoring Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 50. Global Therapeutic Drug Monitoring Percentage 2020-2031: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed